CBD shows anti-proliferative, pro-apoptotic, anti-invasive, and anti-inflammatory properties across multiple cancer types in laboratory and animal studies, with early clinical evidence emerging.
Oncology researchers, cancer patients exploring CBD, and clinicians fielding patient questions about cannabis and cancer.
6+ anti-cancer mechanisms
What the researchers found
The review documents CBD's effects against cancer through multiple mechanisms: inhibiting cell proliferation, promoting cancer cell death, blocking invasion and angiogenesis, and modulating inflammation and immune responses. These effects have been observed in breast, lung, colon, prostate, glioblastoma, and other cancer types.
Why it matters
Cancer patients frequently ask about CBD. This review consolidates the mechanistic evidence showing CBD acts through multiple pathways, while also noting the significant gap between laboratory findings and clinical proof.
The numbers in context
Over 100 phytocannabinoids have been detected in Cannabis sativa. CBD showed effects across at least six distinct anti-cancer mechanisms (anti-proliferative, pro-apoptotic, cytotoxic, anti-invasive, anti-angiogenic, and immunomodulatory).
How the study worked
Comprehensive review of in vitro cell studies, in vivo animal models, and available clinical data on CBD's anticancer properties, covering mechanisms of action and pharmacological profile.
What this study cannot tell us
Most evidence comes from cell cultures and animal models. Clinical data is scarce. Doses used in laboratory studies may not be achievable in humans. CBD's bioavailability challenges are acknowledged but not resolved.
How to read the evidence
Moderate: comprehensive review covering multiple study types, but limited by scarce clinical data.
When this study was published
Published in 2019.
The bigger picture
CBD's advantage over THC for cancer research is its lack of psychoactive effects, making clinical applications more practical. The multi-target nature of CBD is unusual and could make it valuable as an adjunct therapy, though clinical trials remain limited.
Questions still open
- Can the anti-cancer concentrations of CBD achieved in lab dishes be replicated in human tumors? Which cancer types are most likely to benefit from CBD-based therapies?
Common questions
Can CBD cure cancer?
What types of cancer has CBD been studied for?
Read the original research
Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
International journal of molecular sciences, 20(23)
Citation
Kis, Brigitta; Ifrim, Feng Chen; Buda, Valentina; Avram, Stefana; Pavel, Ioana Zinuca; Antal, Diana; Paunescu, Virgil; Dehelean, Cristina Adriana; Ardelean, Florina; Diaconeasa, Zorita; Soica, Codruta; Danciu, Corina. (2019). Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.. International journal of molecular sciences, 20(23). https://doi.org/10.3390/ijms20235905
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk